Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/CO/Grand Junction

Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Grand Junction, CO

Q: How much do paid clinical trials in Grand Junction pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Q: How do I join a study in Grand Junction, CO?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Q: Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

Q: What is the difference between a research center and a hospital study in Grand Junction?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Q: Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Grand Junction typically complete one or two studies per year.

Studies commonly pay $75 to $4,500 per completed study

50 clinical trials are currently recruiting participants within 30 miles of Grand Junction. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

50studies recruiting

2+research centers nearby

3condition categories

Live from the NIH registry

Studies recruiting near Grand Junction right now

Top 25 of 50 recruiting studies, sorted by proximity — each links to its official registry page

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought

Intermountain Health St. Mary's Regional Hospital ( Site 0025) — Grand Junction, Colorado (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06136559)

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Breast Neoplasms, Carcinoma, Ductal, Breast N/A Interventional 725 participants sought

Intermountain Health — Grand Junction, Colorado (1.9 mi) · Sponsor: Natera, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07214532)

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Intracerebral Hemorrhage, Atrial Fibrillation Phase 3 Interventional 700 participants sought

St. Mary's Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: Yale University

See eligibility & contact on ClinicalTrials.gov (NCT03907046)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought

Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05256225)

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Acute Treatment of Migraine Phase 3 Interventional 600 participants sought

Boeson Research GJT — Grand Junction, Colorado (1.9 mi) · Sponsor: Pfizer

See eligibility & contact on ClinicalTrials.gov (NCT04743141)

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma Phase 3 Interventional 398 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT07452458)

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8 Phase 3 Interventional 226 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT07166406)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis, Multiple Sclerosis N/A Observational 2,000 participants sought

TG Therapeutics Investigational Trial Site — Grand Junction, Colorado (1.9 mi) · Sponsor: TG Therapeutics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06433752)

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 3 Interventional 382 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05677490)

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Parkinson's Disease N/A Observational 1,500 participants sought

St. Mary's Hospital and Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: Boston Scientific Corporation

See eligibility & contact on ClinicalTrials.gov (NCT02071134)

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06580314)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought

Colorado West Healthcare System - Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT07218380)

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Metastatic Small Intestinal Adenocarcinoma, Stage III Small Intestinal Adenocarcinoma AJCC v8 Phase 2 Interventional 94 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT04205968)

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Lung Cancer (Diagnosis) N/A Interventional 2,063 participants sought

VA Western Colorado Health Care System — Grand Junction, Colorado (1.9 mi) · Sponsor: bioAffinity Technologies Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07168993)

Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

Open Angle Glaucoma (OAG) N/A Interventional 165 participants sought

ICON Eye Care — Grand Junction, Colorado (1.9 mi) · Sponsor: Avisi Technologies Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07220876)

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Stage III Colon Cancer Phase 2, Phase 3 Interventional 1,912 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05174169)

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer Phase 3 Interventional 330 participants sought

Colorado West Healthcare System dba Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: Amgen

See eligibility & contact on ClinicalTrials.gov (NCT07005128)

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder N/A Observational 2,240 participants sought

Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04242095)

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

Breast Cancer, Advanced Breast Cancer Phase 3 Interventional 510 participants sought

Clinical Trial Site — Grand Junction, Colorado (1.9 mi) · Sponsor: Olema Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06016738)

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT05929768)

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Non-Small Cell Lung Cancer Phase 3 Interventional 780 participants sought

Clinical Study Site — Grand Junction, Colorado (1.9 mi) · Sponsor: Summit Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT06767514)

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion N/A Observational 150 participants sought

SCL Health — Grand Junction, Colorado (1.9 mi) · Sponsor: Bayer

See eligibility & contact on ClinicalTrials.gov (NCT04142437)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04269902)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT03723928)

A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract

Age Related Cataracts Phase 2 Interventional 40 participants sought

ICON Eye Care — Grand Junction, Colorado (1.9 mi) · Sponsor: Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT07395986)

Actively enrolling

Studies you may be able to join near Grand Junction

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Grand Junction

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Primary Care Partners Inc.

★ 3.4

3150 N 12th St, Grand Junction, CO 81506

(970) 256-5211

Website

"I spent one of the worst nights in Delta hospital that I ever had .The bed had half the buttons didn't work and the mattress i had seams like it had …"

— Leroy Foreman, 3★

Western Slope Veterinary Diagnostic Laboratory, CSU

3164 B 1/2 Rd, Grand Junction, CO 81503

(970) 243-0673

Website

Clinical trials in Grand Junction: what's recruiting

The Grand Junction area currently has 50 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Grand Junction, the most active research areas are:

Cancer & Oncology19 studies
Liver & Kidney1 studies
Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Grand Junction, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Grand Junction

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Grand Junction participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Grand Junction pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

How do I join a study in Grand Junction, CO?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

What is the difference between a research center and a hospital study in Grand Junction?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Grand Junction typically complete one or two studies per year.

Paid clinical trials near Grand Junction

Other metros within reach

Provo, UT126 Lakewood, CO1,606 Thornton, CO1,610 Denver, CO1,606 Salt Lake City, UT1,184 Fort Collins, CO154 Colorado Springs, CO203 Aurora, CO1,574

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Grand Junction Bladder Issues Due To Spinal Cord Injury in Grand Junction All conditions

More of CO

Thornton1,610 Denver1,606 Lakewood1,606 Aurora1,574 Colorado Springs203 Greeley156 Fort Collins154

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts